m.8993T&gt;G相关Leigh综合征合并低瓜氨酸血症患儿4例并文献复习

李映雪; 王冬娟; 周茂彬; 孙浩轩; 洪思琦; 蒋莉; 郭艺

doi:10.7499/j.issn.1008-8830.2404036

PDF(769 KB)

HTML

中国当代儿科杂志 ›› 2024, Vol. 26 ›› Issue (9) : 940-945. DOI: 10.7499/j.issn.1008-8830.2404036

论著·临床研究

m.8993T>G相关Leigh综合征合并低瓜氨酸血症患儿4例并文献复习

李映雪¹, 王冬娟², 周茂彬¹, 孙浩轩¹, 洪思琦¹, 蒋莉¹, 郭艺¹

作者信息 +

Leigh syndrome caused by the mitochondrial m.8993T>G mutation with hypocitrullinemia: a report of four cases and literature review

LI Ying-Xue, WANG Dong-Juan, ZHOU Mao-Bin, SUN Hao-Xuan, HONG Si-Qi, JIANG Li, GUO Yi

Author information +

文章历史 +

摘要

目的探索m.8993T>G变异致Leigh综合征的早期诊断生物学标志。方法回顾性分析2014年1月—2024年1月在重庆医科大学附属儿童医院确诊的4例m.8993T>G相关Leigh综合征患儿的临床资料并文献复习。结果 4例患儿血氨基酸和酰基肉碱谱分析发现瓜氨酸降低，其中1例最早于新生儿遗传代谢病筛查发现。目前已报道的m.8993T>G变异合并低瓜氨酸血症的线粒体病患儿（含该研究4例）共26例，其中12例临床表型为Leigh综合征或Leigh样综合征，18例最早于新生儿遗传代谢病筛查发现存在瓜氨酸降低和/或3-羟基异戊酰肉碱（C5-OH）升高。结论低瓜氨酸血症可能是m.8993T>G相关Leigh综合征早期诊断的血清生物学标志物，最早可在新生儿遗传代谢病筛查中发现。

Abstract

Objective To explore early diagnostic biological markers for Leigh syndrome caused by the m.8993T>G mutation. Methods A retrospective analysis was performed on the clinical data of four children diagnosed with m.8993T>G mutation-related mitochondrial disease at the Children's Hospital of Chongqing Medical University from January 2014 to January 2024. Additionally, a literature review was conducted. Results All four children had plasma amino acid and acylcarnitine analyses that revealed decreased citrulline levels, and one child was initially identified through neonatal genetic metabolic disease screening. According to the literature review, there were 26 children with mitochondrial disease and hypocitrullinemia caused by the m.8993T>G mutation (including the four children in this study). Among these, 12 children exhibited clinical phenotypes of Leigh syndrome or Leigh-like syndrome, while 18 children were identified with hypocitrullinemia and/or elevated levels of 3-hydroxyisovalerylcarnitine (C5-OH) during neonatal genetic metabolic disease screening. Conclusions Hypocitrullinemia may serve as a potential biomarker for the early diagnosis of m.8993T>G mutation-associated Leigh syndrome, detectable as early as during neonatal genetic metabolic disease screening.

导出引用

李映雪, 王冬娟, 周茂彬, 孙浩轩, 洪思琦, 蒋莉, 郭艺. m.8993T>G相关Leigh综合征合并低瓜氨酸血症患儿4例并文献复习[J]. 中国当代儿科杂志. 2024, 26(9): 940-945 https://doi.org/10.7499/j.issn.1008-8830.2404036

LI Ying-Xue, WANG Dong-Juan, ZHOU Mao-Bin, SUN Hao-Xuan, HONG Si-Qi, JIANG Li, GUO Yi. Leigh syndrome caused by the mitochondrial m.8993T>G mutation with hypocitrullinemia: a report of four cases and literature review[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(9): 940-945 https://doi.org/10.7499/j.issn.1008-8830.2404036

参考文献

1 Leigh D. Subacute necrotizing encephalomyelopathy in an infant[J]. J Neurol Neurosurg Psychiatry, 1951, 14(3): 216-221. PMID: 14874135. PMCID: PMC499520. DOI: 10.1136/jnnp.14.3.216.
2 中华医学会儿科学分会神经学组, 福棠儿童医学发展研究中心神经内科专业委员会, 中华儿科杂志编辑委员会. Leigh综合征诊断与治疗中国专家共识（2023）[J]. 中华儿科杂志, 2023, 61(12): 1077-1085. PMID: 38018044. DOI: 10.3760/cma.j.cn112140-20230904-00153.
3 Stendel C, Neuhofer C, Floride E, et al. Delineating MT-ATP6-associated disease: from isolated neuropathy to early onset neurodegeneration[J]. Neurol Genet, 2020, 6(1): e393. PMID: 32042921. PMCID: PMC6975175. DOI: 10.1212/NXG.0000000000000393.
4 Baertling F, Rodenburg RJ, Schaper J, et al. A guide to diagnosis and treatment of Leigh syndrome[J]. J Neurol Neurosurg Psychiatry, 2014, 85(3): 257-265. PMID: 23772060. DOI: 10.1136/jnnp-2012-304426.
5 Wongkittichote P, Ganetzky RD, Demczko MM, et al. Low plasma citrulline guiding the diagnosis of a mitochondrial disorder[J]. Clin Chem, 2023, 69(6): 661-664. PMID: 37258485. DOI: 10.1093/clinchem/hvad039.
6 Tise CG, Verscaj CP, Mendelsohn BA, et al. MT-ATP6 mitochondrial disease identified by newborn screening reveals a distinct biochemical phenotype[J]. Am J Med Genet A, 2023, 191(6): 1492-1501. PMID: 36883293. DOI: 10.1002/ajmg.a.63159.
7 Peretz RH, Ah Mew N, Vernon HJ, et al. Prospective diagnosis of MT-ATP6-related mitochondrial disease by newborn screening[J]. Mol Genet Metab, 2021, 134(1-2): 37-42. PMID: 34176718. PMCID: PMC8578202. DOI: 10.1016/j.ymgme.2021.06.007.
8 Balasubramaniam S, Lewis B, Mock DM, et al. Leigh-like syndrome due to homoplasmic m.8993T>G variant with hypocitrullinemia and unusual biochemical features suggestive of multiple carboxylase deficiency (MCD)[J]. JIMD Rep, 2017, 33: 99-107. PMID: 27450367. PMCID: PMC5413447. DOI: 10.1007/8904_2016_559.
9 Mori M, Mytinger JR, Martin LC, et al. m.8993T>G-associated Leigh syndrome with hypocitrullinemia on newborn screening[J]. JIMD Rep, 2014, 17: 47-51. PMID: 25240982. PMCID: PMC4241199. DOI: 10.1007/8904_2014_332.
10 Henriques M, Diogo L, Garcia P, et al. Mitochondrial DNA 8993T>G mutation in a child with ornithine transcarbamylase deficiency and Leigh syndrome: an unexpected association[J]. J Child Neurol, 2012, 27(8): 1059-1061. PMID: 22241703. DOI: 10.1177/0883073811431015.
11 Debray FG, Lambert M, Allard P, et al. Low citrulline in Leigh disease: still a biomarker of maternally inherited Leigh syndrome[J]. J Child Neurol, 2010, 25(8): 1000-1002. PMID: 20472868. DOI: 10.1177/0883073809351983.
12 Enns GM, Bai RK, Beck AE, et al. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load[J]. Mol Genet Metab, 2006, 88(4): 364-371. PMID: 16546428. DOI: 10.1016/j.ymgme.2006.02.001.
13 Carrozzo R, Verrigni D, Rasmussen M, et al. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients[J]. J Inherit Metab Dis, 2016, 39(2): 243-252. PMID: 26475597. DOI: 10.1007/s10545-015-9894-9.
14 Saunders C, Smith L, Wibrand F, et al. CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria[J]. Am J Hum Genet, 2015, 96(2): 258-265. PMID: 25597511. PMCID: PMC4320254. DOI: 10.1016/j.ajhg.2014.12.020.
15 Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S, et al. Progressive deafness-dystonia due to SERAC1 mutations: a study of 67 cases[J]. Ann Neurol, 2017, 82(6): 1004-1015. PMID: 29205472. PMCID: PMC5847115. DOI: 10.1002/ana.25110.
16 Yang H, Yu D. Clinical, biochemical and metabolic characterization of patients with short-chain enoyl-CoA hydratase(ECHS1) deficiency: two case reports and the review of the literature[J]. BMC Pediatr, 2020, 20(1): 50. PMID: 32013919. PMCID: PMC6996175. DOI: 10.1186/s12887-020-1947-z.
17 Wang J, Liu Z, Xu M, et al. Cinical, metabolic, and genetic analysis and follow-up of eight patients with HIBCH mutations presenting with leigh/leigh-like syndrome[J]. Front Pharmacol, 2021, 12: 605803. PMID: 33762937. PMCID: PMC7982470. DOI: 10.3389/fphar.2021.605803.
18 Boyer M, Sowa M, Di Meo I, et al. Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy[J]. Mol Genet Metab, 2018, 124(1): 57-63. PMID: 29526615. DOI: 10.1016/j.ymgme.2018.02.008.
19 Rabier D, Kamoun P. Metabolism of citrulline in man[J]. Amino Acids, 1995, 9(4): 299-316. PMID: 24178879. DOI: 10.1007/BF00807268.
20 庞韦, 田锐, 王瑞兰. 血浆瓜氨酸在肠功能损伤中的临床应用进展[J]. 临床急诊杂志, 2018, 19(4): 274-278. DOI: 10.13201/j.issn.1009-5918.2018.04.017.
21 Elliott KR, Tipton KF. Product inhibition studies on bovine liver carbamoyl phosphate synthetase[J]. Biochem J, 1974, 141(3): 817-824. PMID: 4377108. PMCID: PMC1168187. DOI: 10.1042/bj1410817.